NCT07143669

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-10-17Est. Completion: 2028-07-31

Enrollment target: 750 participants

Locations

AllerVie Clinical Research, Birmingham, Alabama, United States
O'Neal Comprehensive Cancer Center at the UAB, Birmingham, Alabama, United States
Kaiser Permanente San Diego, San Diego, California, United States
Allergy & Asthma Clinical Research of the Bay Area, Walnut Creek, California, United States
Allergy, Asthma, & Immunology Associates of Tampa Bay, Tampa, Florida, United States
Emory University, Atlanta, Georgia, United States
Northwestern Medicine Allergy and Immunology, Evanston, Illinois, United States
Midwest Allergy Sinus Asthma, Normal, Illinois, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Tulane University School of Medicine, New Orleans, Louisiana, United States
AllerVie Health, Glenn Dale, Maryland, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Barnes-Jewish West County Hospital, St Louis, Missouri, United States
Somnos Clinical Research, Lincoln, Nebraska, United States
University of Nebraska, Omaha, Nebraska, United States

Obesity

Obesity is a global health problem that has reached epidemic proportions, affecting more than one billion people worldwi…

Alexandria, EgyptCompleted May 13, 2026

Idiopathic AnaphylaxisDrug AnaphylaxisVenom AnaphylaxisFood Anaphylaxis

This study will explore the possible cause of unexplained, or idiopathic, anaphylaxis. Anaphylaxis is a rapid, life-thre…

Bethesda, United States

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.